4-(6-phenylpyrazolo[1,5-a]pyrimidin-3-yl)quinoline

ID: ALA469055

Chembl Id: CHEMBL469055

PubChem CID: 44223354

Max Phase: Preclinical

Molecular Formula: C21H14N4

Molecular Weight: 322.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc(-c2cnc3c(-c4ccnc5ccccc45)cnn3c2)cc1

Standard InChI:  InChI=1S/C21H14N4/c1-2-6-15(7-3-1)16-12-23-21-19(13-24-25(21)14-16)17-10-11-22-20-9-5-4-8-18(17)20/h1-14H

Standard InChI Key:  QBSQJJUIEKBBLE-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

BMP4 Tchem Bone morphogenetic protein 4 (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 322.37Molecular Weight (Monoisotopic): 322.1218AlogP: 4.61#Rotatable Bonds: 2
Polar Surface Area: 43.08Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.45CX LogP: 4.11CX LogD: 4.11
Aromatic Rings: 5Heavy Atoms: 25QED Weighted: 0.48Np Likeness Score: -1.06

References

1. Cuny GD, Yu PB, Laha JK, Xing X, Liu JF, Lai CS, Deng DY, Sachidanandan C, Bloch KD, Peterson RT..  (2008)  Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors.,  18  (15): [PMID:18621530] [10.1016/j.bmcl.2008.06.052]

Source